Your browser doesn't support javascript.
loading
NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors.
Byrgazov, K; Kastner, R; Gorna, M; Hoermann, G; Koenig, M; Lucini, C B; Ulreich, R; Benesch, M; Strenger, V; Lackner, H; Schwinger, W; Sovinz, P; Haas, O A; van den Heuvel-Eibrink, M; Niemeyer, C M; Hantschel, O; Valent, P; Superti-Furga, G; Urban, C; Dworzak, M N; Lion, T.
Affiliation
  • Byrgazov K; Children's Cancer Research Institute, Vienna, Austria.
  • Kastner R; Children's Cancer Research Institute, Vienna, Austria.
  • Gorna M; CeMM, Research Center for Molecular Medicine of the Austrian Academy of Science, Vienna, Austria.
  • Hoermann G; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Koenig M; Children's Cancer Research Institute, Vienna, Austria.
  • Lucini CB; Children's Cancer Research Institute, Vienna, Austria.
  • Ulreich R; Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
  • Benesch M; Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
  • Strenger V; Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
  • Lackner H; Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
  • Schwinger W; Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
  • Sovinz P; Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
  • Haas OA; Children's Cancer Research Institute, Vienna, Austria.
  • van den Heuvel-Eibrink M; Department of Pediatric Hemato-Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Niemeyer CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Hantschel O; Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany.
  • Valent P; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Superti-Furga G; Division of Hematology and Hemostaseology, Department of Internal Medicine, Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Urban C; CeMM, Research Center for Molecular Medicine of the Austrian Academy of Science, Vienna, Austria.
  • Dworzak MN; Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
  • Lion T; Children's Cancer Research Institute, Vienna, Austria.
Leukemia ; 31(1): 237-240, 2017 01.
Article in En | MEDLINE | ID: mdl-27573554
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oncogene Proteins, Fusion / Drug Resistance, Neoplasm / Receptor, Platelet-Derived Growth Factor beta / Protein Kinase Inhibitors / Eosinophilia / Myeloproliferative Disorders Type of study: Risk_factors_studies Limits: Animals / Humans / Infant Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Type: Article Affiliation country: Austria
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oncogene Proteins, Fusion / Drug Resistance, Neoplasm / Receptor, Platelet-Derived Growth Factor beta / Protein Kinase Inhibitors / Eosinophilia / Myeloproliferative Disorders Type of study: Risk_factors_studies Limits: Animals / Humans / Infant Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Type: Article Affiliation country: Austria